Form 8-K - Current report:
SEC Accession No. 0001641172-25-003620
Filing Date
2025-04-10
Accepted
2025-04-10 16:15:23
Documents
14
Period of Report
2025-04-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 64738
2 ex2-1.htm EX-2.1 1063221
  Complete submission text file 0001641172-25-003620.txt   1471616

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pulm-20250407.xsd EX-101.SCH 3018
4 XBRL LABEL FILE pulm-20250407_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE pulm-20250407_pre.xml EX-101.PRE 24167
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 25828579
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)